SE9201478D0 - Heteroaromatic quinuclidinenes, their use and preparation - Google Patents
Heteroaromatic quinuclidinenes, their use and preparationInfo
- Publication number
- SE9201478D0 SE9201478D0 SE9201478A SE9201478A SE9201478D0 SE 9201478 D0 SE9201478 D0 SE 9201478D0 SE 9201478 A SE9201478 A SE 9201478A SE 9201478 A SE9201478 A SE 9201478A SE 9201478 D0 SE9201478 D0 SE 9201478D0
- Authority
- SE
- Sweden
- Prior art keywords
- carbon
- nitrogen
- represent
- sulphur
- pct
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 8
- 229910052799 carbon Inorganic materials 0.000 abstract 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 4
- 239000005864 Sulphur Chemical group 0.000 abstract 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 229910052760 oxygen Inorganic materials 0.000 abstract 4
- 239000001301 oxygen Substances 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201478A SE9201478D0 (sv) | 1992-05-11 | 1992-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
| EP93910521A EP0640082A1 (en) | 1992-05-11 | 1993-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
| AU40985/93A AU674515B2 (en) | 1992-05-11 | 1993-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
| US08/325,407 US5599937A (en) | 1992-05-11 | 1993-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
| PCT/SE1993/000415 WO1993023395A1 (en) | 1992-05-11 | 1993-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
| JP52012793A JP3314933B2 (ja) | 1992-05-11 | 1993-05-11 | ヘテロ芳香族キヌクリジネン、それらの使用および製造 |
| CA002135487A CA2135487C (en) | 1992-05-11 | 1993-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9201478A SE9201478D0 (sv) | 1992-05-11 | 1992-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9201478D0 true SE9201478D0 (sv) | 1992-05-11 |
Family
ID=20386208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9201478A SE9201478D0 (sv) | 1992-05-11 | 1992-05-11 | Heteroaromatic quinuclidinenes, their use and preparation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5599937A (sv) |
| EP (1) | EP0640082A1 (sv) |
| JP (1) | JP3314933B2 (sv) |
| AU (1) | AU674515B2 (sv) |
| CA (1) | CA2135487C (sv) |
| SE (1) | SE9201478D0 (sv) |
| WO (1) | WO1993023395A1 (sv) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5612351A (en) * | 1994-11-08 | 1997-03-18 | Novo Nordisk A/S | Method of treating urinary bladder dysfunctions |
| US5733912A (en) * | 1997-02-19 | 1998-03-31 | Abbott Laboratories | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission |
| AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
| AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
| ATE341548T1 (de) | 2001-07-06 | 2006-10-15 | Neurosearch As | Neue verbindungen, deren herstellung und verwendung |
| ATE355293T1 (de) * | 2001-09-12 | 2006-03-15 | Pharmacia & Upjohn Co Llc | Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten |
| DE10144888A1 (de) * | 2001-09-12 | 2003-03-27 | Cognis Deutschland Gmbh | Verfahren zur Bestimmung des Enantiomerenverhältnisses von Trimethylcyclopenten-Derivaten |
| EP1432707B1 (en) | 2001-10-02 | 2012-03-28 | Pharmacia & Upjohn Company LLC | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| US6894042B2 (en) * | 2002-02-19 | 2005-05-17 | Pharmacia & Upjohn Company | Azabicyclic compounds for the treatment of disease |
| US6858613B2 (en) * | 2002-02-19 | 2005-02-22 | Pfizer Inc. | Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease |
| NZ536197A (en) | 2002-05-30 | 2006-08-31 | Neurosearch As | 3-substituted quinuclidines and their use |
| MXPA05004723A (es) * | 2002-11-01 | 2005-12-05 | Pharmacia & Upjohn Co Llc | Compuestos que tienen ambas actividades del agonista alfa 7 nachr y el antagonista 5ht para el tratamiento de las enfermedades del snc. |
| SE0400970D0 (sv) | 2004-04-14 | 2004-04-14 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| AU2009316557B2 (en) | 2008-11-19 | 2015-08-27 | Envivo Pharmaceuticals, Inc. | Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl) benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
| BRPI1014793A2 (pt) * | 2009-05-11 | 2016-04-05 | Envivo Pharmaceuticals Inc | tratamento de distúrbios de cognição com determinados receptores de ácido alfa-7-nicotínico em combinação com inibidores de acetil-colinesterase |
| CA2799744C (en) | 2010-05-17 | 2020-01-28 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
| US9585877B2 (en) | 2012-05-08 | 2017-03-07 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0261763B1 (en) * | 1986-06-27 | 1994-02-09 | Beecham Group Plc | Novel bridged bicyclic N-heterocycles |
| NZ224237A (en) * | 1987-04-15 | 1991-04-26 | Beecham Group Plc | Bicyclic compounds (n bridged compounds) |
| GB8717446D0 (en) * | 1987-07-23 | 1987-08-26 | Merck Sharp & Dohme | Chemical compounds |
| NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
| DE3877470T2 (de) * | 1987-09-10 | 1993-06-24 | Merck Sharp & Dohme | Oxazole und thiazole zur behandlung seniler demenz. |
| IL88156A (en) * | 1987-11-13 | 1997-02-18 | Novo Nordisk As | Azacyclic compounds their preparation and pharmaceutical compositions containing them |
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| EP0363085A3 (en) * | 1988-10-03 | 1991-03-27 | Beecham Group Plc | Novel compounds |
| EP0427390B1 (en) * | 1989-10-07 | 1996-03-27 | Beecham Group Plc | Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them |
| DE4009565A1 (de) * | 1990-03-24 | 1991-09-26 | Merck Patent Gmbh | Indolderivate |
-
1992
- 1992-05-11 SE SE9201478A patent/SE9201478D0/sv unknown
-
1993
- 1993-05-11 CA CA002135487A patent/CA2135487C/en not_active Expired - Fee Related
- 1993-05-11 US US08/325,407 patent/US5599937A/en not_active Expired - Fee Related
- 1993-05-11 JP JP52012793A patent/JP3314933B2/ja not_active Expired - Fee Related
- 1993-05-11 EP EP93910521A patent/EP0640082A1/en not_active Withdrawn
- 1993-05-11 WO PCT/SE1993/000415 patent/WO1993023395A1/en not_active Ceased
- 1993-05-11 AU AU40985/93A patent/AU674515B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2135487C (en) | 1999-12-14 |
| US5599937A (en) | 1997-02-04 |
| WO1993023395A1 (en) | 1993-11-25 |
| AU4098593A (en) | 1993-12-13 |
| AU674515B2 (en) | 1997-01-02 |
| JPH08500575A (ja) | 1996-01-23 |
| EP0640082A1 (en) | 1995-03-01 |
| JP3314933B2 (ja) | 2002-08-19 |
| CA2135487A1 (en) | 1993-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9201478D0 (sv) | Heteroaromatic quinuclidinenes, their use and preparation | |
| FI932229A0 (fi) | Azabicykliska bryggderivat | |
| AU1889392A (en) | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
| HU9601218D0 (en) | Distamycin a analogue utilizable as antitumoral and antiviral medicines | |
| ZA924527B (en) | Azanorbornane derivatives | |
| ATE172968T1 (de) | Substituierte azadioxacycloalkene und ihre verwendung als fungizide | |
| KR970704438A (ko) | 티아졸 및 티아디아졸 화합물의 D 도파민 수용체 리간드로서의 용도(Use of Thiazole and Thiadiazole Compounds as D Dopamine Receptor Ligands) | |
| FI943499A0 (sv) | Syrasurrogat innehållande tetrahedro-1H-benzazepinoner | |
| AU3191293A (en) | New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them | |
| AU648285B2 (en) | Coating material, process for producing it and its use | |
| DK259589D0 (da) | Joderede, ikke-ioniske trijodbenzenforbindelser og kontrastmiddel indeholdende dem | |
| SE9201076D0 (sv) | The use of old drugs for the treatment of diabetes | |
| AU4304596A (en) | A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same | |
| DE3887102D1 (de) | Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen. | |
| ES2087567T3 (es) | Derivados antibioticos de 7'-amino-naftazarina. | |
| AU7610194A (en) | Thiocarbamoyl compounds used as antimicrobial agents | |
| AU2859792A (en) | 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes | |
| YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE | |
| DE59200787D1 (de) | 6-Thiono-5,6-dihydro-dibenz[b,e]azepin-11-on-11-oxime und ihre Verwendung als retrovirale Mittel. |